The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic Global Challenges, Global Solutions: Workshop Summary (2010) / Chapter Skim
Currently Skimming:
Appendix E Forum Member Biographies
Appendix E Forum Member Biographies
Pages 397-418
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 397... ...
He completed his residency in internal medicine and a clinical fellowship in infectious diseases at Massachusetts General Hospital, Boston, after which he moved to Stanford for a postdoctoral fellowship in 1986 and joined the faculty there in 1994. His research focus is on understanding the structure and role of the human indigenous microbial communities in health and disease.
|
From page 398... ...
in 2001, the Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation in 2002, an NIH Director's Pioneer Award in 2006, and a Doris Duke Distinguished Clinical Scientist Award in 2006. He is also a fellow of the American Academy of Microbiology.
|
From page 399... ...
Public Health Service. In 2001 she came to her current position at Emory University, directing a center focused on emerging infectious diseases and other urgent threats to health, including terrorism.
|
From page 400... ...
An internationally recognized drug discoverer with over 20 invited speaker presentations, he has been a member of the IOM Forum on Microbial Threats since 1997 and is on the Editorial Advisory Board of Current Pharmaceutical Design and the Faculty of 1000 Biology. In February 2009, he established SJ Brickner Consulting, LLC, which primarily offers consulting services on all aspects of medicinal chemistry and drug design related to the discovery and development of new antibiotics.
|
From page 401... ...
Gail H Cassell, Ph.D., is currently vice president, Scientific Affairs, and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company, in Indianapolis, Indiana.
|
From page 402... ...
Mark B Feinberg, M.D., Ph.D., is vice president for medical affairs and policy in global vaccine and infectious diseases at Merck & Co., Inc., and is responsible for global efforts to implement vaccines to achieve the greatest health benefits, including efforts to expand access to new vaccines in the developing world.
|
From page 403... ...
Dr. Feinberg also founded and served as the medical director of the Hope Clinic of the Emory Vaccine Center -- a clinical research facility devoted to the clinical evaluation of novel vaccines and to translational research studies of human immune system biology.
|
From page 404... ...
from the Albert Einstein College of Medicine; did residency and fellowship training at the Hospital of the University of Pennsylvania and at the University of California, Los Angeles (UCLA) , where he was also chief medical resident; and is board certified in internal medicine, oncology, and infectious diseases.
|
From page 405... ...
Recent honors and awards include being named an honorary member of the American Society of Tropical Medicine and Hygiene in 2002, an associate member of the National Academy of Medicine in 2002, an honorary member of the Society of Internal Medicine in 2000, and a distinguished visitor at the Faculty of Medical Sciences, University of Cordoba, Argentina, in 1999. In 1988 he received the Golden Medal for Outstanding Contribution in the Field of Infectious Diseases awarded by Trnava University, Slovakia.
|
From page 406... ...
and continued at the NCI as a senior staff fellow in molecular oncology. She moved into health science administration in 1986, focusing on respiratory pathogens, particularly vaccine development.
|
From page 407... ...
of CDC. He is a member of the IOM, and has been awarded the 2004 Award for Excellence of the American Public Health Association, the 2005 Donald Mackay Award from the American Society for Tropical Medicine and Hygiene, and the 2007 Heinz Award on the Human Condition.
|
From page 408... ...
He joined Aventis Pasteur (then Connaught Labs) in 1987 as clinical research coordinator and has held research and development positions of increasing responsibility, including clinical research manager and director of clinical operations.
|
From page 409... ...
Dr. Kester's previous military medical research assignments have included: director of the WRAIR Malaria Serology Reference Laboratory; chief, Clinical Malaria Vaccine Development Program; Chief of the WRAIR Clinical Trials Center; and director of the WRAIR Division of Regulated Activities.
|
From page 410... ...
, and holds membership in the American Epidemiological Society, the American Society for Microbiology, and the American Society for Tropical Medicine and Hygiene. She is also a member of IDSA's National and Global Public Health Committee and of the Institute of Medicine's Forum on Microbial Threats and serves as a clinical associate professor of medicine (infectious diseases)
|
From page 411... ...
He was cochair of the NAS Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, and he recently chaired an IOM study committee related to vaccines for the protection of the military against naturally occurring infectious disease threats. Edward McSweegan, Ph.D., is a program officer at NIAID.
|
From page 412... ...
in microbiology and immunology from The Albany Medical College in 1987. Following 4 years of post-doctoral studies on yeast molecular genetics at the National Institutes of Health in Bethesda, Maryland, Paul joined the Parke-Davis Pharmaceutical Research Division of WarnerLambert Company in Ann Arbor, Michigan, in 1990 as a senior scientist in the infectious diseases department, where he developed a number of novel screens and mechanism-of-action tools.
|
From page 413... ...
He currently serves on the IOM Forum on Microbial Threats. He has also served on the IOM Committee to Ensure Safe Food from Production to Consumption, and on the IOM Committee on the Department of Defense Persian Gulf Syndrome Comprehensive Clinical Evaluation Program, and as a reviewer for the IOM report Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response.
|
From page 414... ...
He has received honorary degrees in science, law, and medicine for his research contributions and was honored in 1999 by HM Queen Elizabeth II as a Commander of the British Empire for his contributions to international security. He is a Fellow of the Royal Society, the Royal College of Pathologists, and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University, and a member of the Council for Foreign Relations.
|
From page 415... ...
She received her baccalaureate, cum laude, from the University of Massachusetts and is a graduate of the George Washington University programs in public policy and in editing and publications. She is a member of Women in Government Relations, the American Society of Association Executives, and AAAS.
|
From page 416... ...
and the IOM Committee on Emerging Microbial Threats to Health in the 21st Century (2001-2003)
|
From page 417... ...
Currently, Dr. Trostle leads the USAID Infectious Disease Surveillance Initiative as well as the Avian Influenza Unit.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.